TR200102700T2 - Treatment of abdominal hernia (hiatal hernia). - Google Patents
Treatment of abdominal hernia (hiatal hernia).Info
- Publication number
- TR200102700T2 TR200102700T2 TR2001/02700T TR200102700T TR200102700T2 TR 200102700 T2 TR200102700 T2 TR 200102700T2 TR 2001/02700 T TR2001/02700 T TR 2001/02700T TR 200102700 T TR200102700 T TR 200102700T TR 200102700 T2 TR200102700 T2 TR 200102700T2
- Authority
- TR
- Turkey
- Prior art keywords
- hernia
- treatment
- hiatal
- abdominal
- hiatal hernia
- Prior art date
Links
- 208000034991 Hiatal Hernia Diseases 0.000 title abstract 2
- 206010020028 Hiatus hernia Diseases 0.000 title abstract 2
- 206010060954 Abdominal Hernia Diseases 0.000 title 1
- -1 amine hydrochloride Chemical class 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 abstract 1
- 238000010992 reflux Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
R1 VE R2'nin biribirleridnden bagimsiz olarak H veya metil oldugu formül I'in bir bilesimi veya bunlarin farmasötik olarak kabulkabul edilen tuzlari (örnegin, seçime bagli olarak monihdrati yapisinda N,N-dimetil-1-[1-(4-klorofenil) sislobütil]-3-metilbtil amin hidroklorit) hiatal hernia ve reflux oesephagitis in tedavisi için kullailirlar.A combination of formula I wherein R1 and R2 are independently H or methyl from each other, or their pharmaceutically acceptable salts (for example, N, N-dimethyl-1- [1- (4-chlorophenyl) cyslobutyl optionally in the monihdrati structure) ] -3-methylbethyl amine hydrochloride) are used for the treatment of hiatal hernia and reflux oesephagitis.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12511699P | 1999-03-19 | 1999-03-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200102700T2 true TR200102700T2 (en) | 2002-04-22 |
Family
ID=22418261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2001/02700T TR200102700T2 (en) | 1999-03-19 | 2000-03-17 | Treatment of abdominal hernia (hiatal hernia). |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1169028A1 (en) |
| JP (1) | JP2002539249A (en) |
| KR (1) | KR20030006909A (en) |
| CN (1) | CN1376061A (en) |
| AU (1) | AU3894400A (en) |
| BG (1) | BG106000A (en) |
| BR (1) | BR0009160A (en) |
| CA (1) | CA2367035A1 (en) |
| CZ (1) | CZ20013279A3 (en) |
| HK (1) | HK1044703A1 (en) |
| HU (1) | HUP0200498A2 (en) |
| IL (1) | IL145242A0 (en) |
| MX (1) | MXPA01009463A (en) |
| NO (1) | NO20014476L (en) |
| NZ (1) | NZ514013A (en) |
| PL (1) | PL351081A1 (en) |
| SK (1) | SK13392001A3 (en) |
| TR (1) | TR200102700T2 (en) |
| WO (1) | WO2000056307A1 (en) |
| ZA (1) | ZA200107679B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103006833B (en) * | 2012-12-31 | 2014-02-12 | 代凤玲 | Medicine for hiatus hernia postoperative rehabilitation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2675573B2 (en) * | 1988-03-31 | 1997-11-12 | 科研製薬株式会社 | Brain function improver |
-
2000
- 2000-03-17 WO PCT/US2000/007112 patent/WO2000056307A1/en not_active Ceased
- 2000-03-17 JP JP2000606212A patent/JP2002539249A/en not_active Withdrawn
- 2000-03-17 CN CN00807531A patent/CN1376061A/en active Pending
- 2000-03-17 HU HU0200498A patent/HUP0200498A2/en unknown
- 2000-03-17 PL PL00351081A patent/PL351081A1/en unknown
- 2000-03-17 MX MXPA01009463A patent/MXPA01009463A/en unknown
- 2000-03-17 KR KR1020017011958A patent/KR20030006909A/en not_active Withdrawn
- 2000-03-17 NZ NZ514013A patent/NZ514013A/en not_active Application Discontinuation
- 2000-03-17 IL IL14524200A patent/IL145242A0/en unknown
- 2000-03-17 BR BR0009160-0A patent/BR0009160A/en not_active Application Discontinuation
- 2000-03-17 HK HK02104606.6A patent/HK1044703A1/en unknown
- 2000-03-17 EP EP00918070A patent/EP1169028A1/en not_active Withdrawn
- 2000-03-17 CA CA002367035A patent/CA2367035A1/en not_active Abandoned
- 2000-03-17 CZ CZ20013279A patent/CZ20013279A3/en unknown
- 2000-03-17 TR TR2001/02700T patent/TR200102700T2/en unknown
- 2000-03-17 AU AU38944/00A patent/AU3894400A/en not_active Abandoned
- 2000-03-17 SK SK1339-2001A patent/SK13392001A3/en unknown
-
2001
- 2001-09-14 NO NO20014476A patent/NO20014476L/en unknown
- 2001-09-18 ZA ZA200107679A patent/ZA200107679B/en unknown
- 2001-10-10 BG BG106000A patent/BG106000A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20013279A3 (en) | 2002-07-17 |
| IL145242A0 (en) | 2002-06-30 |
| EP1169028A1 (en) | 2002-01-09 |
| NO20014476L (en) | 2001-10-29 |
| JP2002539249A (en) | 2002-11-19 |
| HK1044703A1 (en) | 2002-11-01 |
| BG106000A (en) | 2002-06-28 |
| AU3894400A (en) | 2000-10-09 |
| CN1376061A (en) | 2002-10-23 |
| SK13392001A3 (en) | 2002-04-04 |
| KR20030006909A (en) | 2003-01-23 |
| PL351081A1 (en) | 2003-03-10 |
| ZA200107679B (en) | 2003-06-18 |
| MXPA01009463A (en) | 2004-03-19 |
| NO20014476D0 (en) | 2001-09-14 |
| NZ514013A (en) | 2001-09-28 |
| WO2000056307A1 (en) | 2000-09-28 |
| HUP0200498A2 (en) | 2002-08-28 |
| CA2367035A1 (en) | 2000-09-28 |
| BR0009160A (en) | 2002-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0215042A (en) | substituted phenyl naphthalenes as estrogenic agents | |
| TR200200579T2 (en) | Amino-thyrazolpyridine derivatives. | |
| NO20021328L (en) | Pyrazolopyrimidia as therapeutic agents | |
| DK1392666T3 (en) | Biologically active methylene blue derivatives | |
| TR200102646T2 (en) | Treating eating disorders. | |
| TR199900648T2 (en) | Lipid d�zeylerini d���rmek i�in sibutramin analoglar�n�n kullan�m�. | |
| DE60230127D1 (en) | INHIBITORS OF INTEGRIN ALPHA-V-BETA-6 | |
| ATE495187T1 (en) | DALDA ANALOGUES AND THEIR USE | |
| NO20012194L (en) | CRF receptor antagonists and associated methods | |
| TR200102178T2 (en) | CRF receptor antagonists and related methods. | |
| DK1230236T3 (en) | Compound with growth hormone releasing properties | |
| DK1379508T3 (en) | N- (aryl) -2arylethenesulfonamides and therapeutic uses thereof | |
| DK1007023T3 (en) | 1- [1- (4-Chlorophenyl) cyclobutyl] -3-methylbutylamine derivatives for lowering urine levels in humans | |
| TR200201128T2 (en) | Tetrahydrothiopyraniphalazinone derivatives as PDE4 inhibitors. | |
| WO2000056315A8 (en) | Treatment of pain | |
| DK1483243T3 (en) | Preparation of N1- (2'-pyridyl) -1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines | |
| DE60121048D1 (en) | PYRAZINOi1'2 ': 1,6öPYRIDOi3,4-BöINDOLDERIVATE | |
| TR200102700T2 (en) | Treatment of abdominal hernia (hiatal hernia). | |
| DK1169029T3 (en) | Use of sibutramine or a derivative thereof for the treatment of sleep disorders | |
| ATE250058T1 (en) | CRF RECEPTOR ANTAGONISTS AND RELATED METHODS | |
| TR200102699T2 (en) | Treatment of chronic joint disorder (osteoarthritis) | |
| NO20042138L (en) | Compounds and Methods for the Treatment of Hyperactive Bladder | |
| ES2355624T8 (en) | PIRROLIDINOHYDROQUINAZOLINS. | |
| MXPA01009469A (en) | Treatment to lower platelet adhesiveness. | |
| MXPA01009468A (en) | Treatment of pulmonary hypertension. |